Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Fisher & Paykel Healthcare Yönetim
Yönetim kriter kontrolleri 3/4
Fisher & Paykel Healthcare's CEO'su Lewis Gradon, Apr2016 tarihinde atandı, in görev süresi 8.5 yıldır. in toplam yıllık tazminatı NZ$ 3.53M olup, şirket hissesi ve opsiyonları dahil olmak üzere 50.6% maaş ve 49.4% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.098% ine doğrudan sahiptir ve bu hisseler NZ$ 20.09M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.4 yıl ve 5.9 yıldır.
Anahtar bilgiler
Lewis Gradon
İcra Kurulu Başkanı
NZ$3.5m
Toplam tazminat
| CEO maaş yüzdesi | 50.6% |
| CEO görev süresi | 8.5yrs |
| CEO sahipliği | 0.1% |
| Yönetim ortalama görev süresi | 3.4yrs |
| Yönetim Kurulu ortalama görev süresi | 4.5yrs |
Son yönetim güncellemeleri
Recent updates
Here's Why Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Compensation Is The Least Of Shareholders Concerns
Aug 21
Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Jul 29Fisher & Paykel Healthcare (NZSE:FPH) Will Want To Turn Around Its Return Trends
Jul 11Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Investors Are Less Pessimistic Than Expected
Jun 22There May Be Reason For Hope In Fisher & Paykel Healthcare's (NZSE:FPH) Disappointing Earnings
Jun 05Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?
Mar 27Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
Feb 22Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Business Is Yet to Catch Up With Its Share Price
Feb 05Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares Could Be 31% Above Their Intrinsic Value Estimate
Jan 03We Think Fisher & Paykel Healthcare (NZSE:FPH) Can Stay On Top Of Its Debt
Nov 30Fisher & Paykel Healthcare (NZSE:FPH) Could Be Struggling To Allocate Capital
Nov 12Estimating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Aug 28Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
Aug 10Here's Why Fisher & Paykel Healthcare (NZSE:FPH) Can Manage Its Debt Responsibly
Jul 02Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
May 01Returns On Capital Signal Tricky Times Ahead For Fisher & Paykel Healthcare (NZSE:FPH)
Jan 23Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Dec 27Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Oct 28Shareholders Are Optimistic That Fisher & Paykel Healthcare (NZSE:FPH) Will Multiply In Value
Oct 13Fisher & Paykel Healthcare (NZSE:FPH) Has A Pretty Healthy Balance Sheet
Sep 28Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Jul 24A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital
Jul 10Fisher & Paykel Healthcare (NZSE:FPH) Seems To Use Debt Quite Sensibly
Jun 12A Look At The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Apr 17Fisher & Paykel Healthcare (NZSE:FPH) Could Become A Multi-Bagger
Apr 04Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Mar 06With EPS Growth And More, Fisher & Paykel Healthcare (NZSE:FPH) Is Interesting
Jan 22Why The 41% Return On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Should Have Your Attention
Dec 26Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Dec 05This Is The Reason Why We Think Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Deserves A Bump Up To Their Compensation
Aug 11Is Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Worth NZ$31.6 Based On Its Intrinsic Value?
Aug 01Do Fisher & Paykel Healthcare's (NZSE:FPH) Earnings Warrant Your Attention?
Jul 07Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Jun 24CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Mar 31 2024 | NZ$4m | NZ$2m | NZ$133m |
| Dec 31 2023 | n/a | n/a | NZ$197m |
| Sep 30 2023 | n/a | n/a | NZ$262m |
| Jun 30 2023 | n/a | n/a | NZ$256m |
| Mar 31 2023 | NZ$3m | NZ$2m | NZ$250m |
| Dec 31 2022 | n/a | n/a | NZ$251m |
| Sep 30 2022 | n/a | n/a | NZ$251m |
| Jun 30 2022 | n/a | n/a | NZ$314m |
| Mar 31 2022 | NZ$4m | NZ$2m | NZ$377m |
| Dec 31 2021 | n/a | n/a | NZ$449m |
| Sep 30 2021 | n/a | n/a | NZ$521m |
| Jun 30 2021 | n/a | n/a | NZ$522m |
| Mar 31 2021 | NZ$4m | NZ$2m | NZ$524m |
| Dec 31 2020 | n/a | n/a | NZ$458m |
| Sep 30 2020 | n/a | n/a | NZ$392m |
| Jun 30 2020 | n/a | n/a | NZ$339m |
| Mar 31 2020 | NZ$3m | NZ$1m | NZ$287m |
| Dec 31 2019 | n/a | n/a | NZ$260m |
| Sep 30 2019 | n/a | n/a | NZ$233m |
| Jun 30 2019 | n/a | n/a | NZ$221m |
| Mar 31 2019 | NZ$3m | NZ$1m | NZ$209m |
| Dec 31 2018 | n/a | n/a | NZ$208m |
| Sep 30 2018 | n/a | n/a | NZ$206m |
| Jun 30 2018 | n/a | n/a | NZ$198m |
| Mar 31 2018 | NZ$2m | NZ$993k | NZ$190m |
Tazminat ve Piyasa: Lewis 'nin toplam tazminatı ($USD 2.22M ), NZ pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 4.54M ).
Tazminat ve Kazançlar: Lewis şirketinin tazminatı %20'den fazla artarken, şirketin kazancı geçen yıl %20'den fazla düştü.
CEO
Lewis Gradon (63 yo)
8.5yrs
Görev süresi
NZ$3,533,971
Tazminat
Mr. Lewis G. Gradon has been the Chief Executive Officer, Managing Director & Executive Director at Fisher & Paykel Healthcare Corporation Limited since April 1, 2016. He served as the Senior Vice Presiden...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| MD, CEO & Executive Director | 8.5yrs | NZ$3.53m | 0.098% NZ$ 20.6m | |
| Chief Financial Officer | 5.6yrs | Veri yok | 0.0045% NZ$ 952.6k | |
| COO & GM of Respiratory Humidification | less than a year | Veri yok | 0.00060% NZ$ 126.4k | |
| Vice President of Products & Technology | 8.5yrs | Veri yok | 0.019% NZ$ 4.0m | |
| Head of Capital Markets & Investor Relations | no data | Veri yok | Veri yok | |
| Company Secretary & General Counsel | less than a year | Veri yok | Veri yok | |
| Senior Communications & Investor Relations Manager | no data | Veri yok | Veri yok | |
| VP of Sales & Marketing and President of North America & Europe | less than a year | Veri yok | 0.029% NZ$ 6.1m | |
| Vice President of Human Resources | 4yrs | Veri yok | Veri yok | |
| Vice President of Supply Chain | 2.8yrs | Veri yok | Veri yok | |
| Vice President of Corporate | no data | Veri yok | Veri yok | |
| General Manager of Airvo Optiflow | no data | Veri yok | Veri yok |
3.4yrs
Ortalama Görev Süresi
Deneyimli Yönetim: FPH 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.4 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| MD, CEO & Executive Director | 8.5yrs | NZ$3.53m | 0.098% NZ$ 20.6m | |
| Non-Executive Director | 22.9yrs | NZ$188.15k | 0.15% NZ$ 32.4m | |
| Independent Chairman of the Board | 5.9yrs | NZ$220.74k | 0.0013% NZ$ 267.7k | |
| Independent Non-Executive Director | 3yrs | NZ$212.77k | 0.0023% NZ$ 486.8k | |
| Member of EcoDesign Advisory Board | no data | Veri yok | Veri yok | |
| Non-Executive Director | no data | Veri yok | Veri yok | |
| Non-Executive Independent Director | less than a year | NZ$93.48k | 0.00032% NZ$ 67.4k | |
| Independent Non-Executive Director | 7.3yrs | NZ$179.08k | 0.00065% NZ$ 137.0k | |
| Independent Non-Executive Director | 2.3yrs | NZ$160.13k | 0.00033% NZ$ 69.5k | |
| Member of EcoDesign Advisory Board | no data | Veri yok | Veri yok | |
| Member of EcoDesign Advisory Board | no data | Veri yok | Veri yok | |
| Member of EcoDesign Advisory Board | no data | Veri yok | Veri yok |
4.5yrs
Ortalama Görev Süresi
63yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: FPH 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.9 yıldır).